Oxford Biomedica plc

546.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:OXBHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 10.60%
Div yield —
ROE (89.69%)
Biotechnology
Beta (5Y) 1.07
PE TTM —
TSR TTM (16.89%)
Mkt cap £663.2M
ROIC (20.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
600p
9.89%
(5.05%)
Hold 4|12|5|3|4
4Q25
1Q26
2Q26
3Q26
Earnings per share£
5.47
6.10
6.82
7.19
13.51%
22.33%
42.58%
37.17%
Revenue£M
72.68
76.18
80.45
78.84
13.39%
16.90%
16.91%
10.76%
Peers (US$892.3M)
Cap (US$)
PE
393.9M
203.0x
Capital
TTM
5Y
10Y
Leveragex
1.792
0.065
0.065
EBIT/Intx
2.820
0.711
0.558
Own earn%
5.94
35.72
38.70
Sh yield%
30.17
37.94
37.52
Owners
Insiders/Inst%
1.93
59.83
Short interest%
0.73
SBC / revenue%
3.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
19–24
$1 testx
—
Incr. ROIC%
14